ArticleBlood research2024
PD-1 inhibitors plus chemotherapy for refractory EBV-positive DLBCL: a retrospective analysis.
Youli Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleBlood research2024
Youli Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.